Document:

Exhibit 10.2

 

VUZIX CORPORATION

SERIES A PREFERED STOCK

INVESTOR’S RIGHTS AGREEMENT

 

This Series A Preferred
Stock Investor’s Rights Agreement (this “Agreement”) is made and entered into as of January 2, 2015,
by and between Vuzix Corporation, a Delaware corporation (the “Company”) and Intel Corporation, a Delaware corporation
(“Purchaser”).

 

This Agreement is made
pursuant to the Series A Preferred Stock Purchase Agreement, dated as of the date hereof, between the Company and Purchaser
(the “Purchase Agreement”).

 

The Company and each Purchaser
hereby agrees as follows:

 

		1.	Definitions.

 

Capitalized terms used
and not otherwise defined herein that are defined in the Purchase Agreement shall have the meanings given such terms in the Purchase
Agreement.

 

As used in this Agreement,
the following terms shall have the following meanings:

 

“Advice” shall
have the meaning set forth in Section 7(d).

 

“Effectiveness
Date” means, with respect to the Initial Registration Statement required to be filed hereunder, May 31, 2015, and with
respect to any additional Registration Statements which may be required pursuant to Section 2(c) or Section 3(c), the
90th calendar day following the date on which an additional Registration Statement is required to be filed hereunder; provided, however,
that in the event the Company is notified by the Commission that one or more of the above Registration Statements will not be reviewed
or is no longer subject to further review and comments, the Effectiveness Date as to such Registration Statement shall be the fifth
Trading Day following the date on which the Company is so notified if such date precedes the dates otherwise required above, provided,
further, if such Effectiveness Date falls on a day that is not a Trading Day, then the Effectiveness Date shall be the next succeeding
Trading Day.

 

“Effectiveness
Period” shall have the meaning set forth in Section 2(a).

 

“Exchange
Act” means the Securities and Exchange Act of 1934, as amended.

 

“Event”
shall have the meaning set forth in Section 2(d).

 

“Event
Date” shall have the meaning set forth in Section 2(d).

 

“Filing
Date” means (i) with respect to the Initial Registration Statement required hereunder, the earlier of February 14, 2015
and the 45th calendar day following the Closing Date, and (ii) with respect to any additional Registration Statements
which may be required pursuant to Section 2(c) or Section 3(c), no later than the 5th Business Day after the earliest
practical date on which the Company is permitted by SEC Guidance to file such additional Registration Statement related to the
Registrable Securities.

 

    	 

    	 

    

  

“Holder”
or “Holders” means the holder or holders, as the case may be, from time to time of Registrable Securities.

 

“Indemnified
Party” shall have the meaning set forth in Section 6(c).

 

“Indemnifying
Party” shall have the meaning set forth in Section 6(c).

 

“Initial
Registration Statement” means the initial Registration Statement filed pursuant to this Agreement.

 

“Losses”
shall have the meaning set forth in Section 6(a).

 

“Prospectus”
means the prospectus included in a Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated
by the Commission pursuant to the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the
terms of the offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments
and supplements to the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to
be incorporated by reference in such Prospectus.

 

“Registrable
Securities” means, as of any date of determination, (a) all of the shares of Common Stock then issuable upon conversion
of the Series A Preferred Stock (the “Conversion Shares”), (b) all shares of Common Stock issuable as dividends
or other distributions with respect to the Series A Preferred Stock (the “Dividend Shares”), and (c) all
shares of Common Stock, and all shares of Common Stock then issuable upon conversion or exercise of any other securities, issued
to the Holders with respect to the preemptive rights and other rights contained in the Purchase Agreement, including, but not limited
to, the rights granted pursuant to Sections 4.15, 4.16 and 4.21 of the Purchase Agreement (the “Preemptive Shares”),
and (d) any securities issued or then issuable upon any stock split, dividend or other distribution, recapitalization or similar
event with respect; provided, however, that any such Registrable Securities shall cease to be Registrable Securities
(and the Company shall not be required to maintain the effectiveness of any, or file another, Registration Statement hereunder
with respect thereto) for so long as (x) a Registration Statement with respect to the sale of such Registrable Securities is declared
effective by the Commission under the Securities Act and such Registrable Securities have been disposed of by the Holder in accordance
with such effective Registration Statement, or (y) such Registrable Securities have been previously sold in accordance with
Rule 144.

 

    	2

    	 

    

  

“Registration
Statement” means any registration statement required to be filed hereunder pursuant to Section 2(a) and any additional
registration statements contemplated by Section 2(c) or Section 3(c), including (in each case) the Prospectus, amendments and supplements
to any such registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto, and all material
incorporated by reference or deemed to be incorporated by reference in any such registration statement.

 

“Rule
415” means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose
and effect as such Rule.

 

“Rule
424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted
from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose
and effect as such Rule.

 

“SEC
Guidance” means (i) any publicly-available written or oral guidance of the Commission staff, or any comments, requirements
or requests of the Commission staff and (ii) the Securities Act.

 

“Securities
Act” means the Securities Act of 1933, as amended.

 

“Selling
Stockholder Questionnaire” shall have the meaning set forth in Section 3(a).

 

“Series
A Preferred Stock” means the Series A Preferred Stock of the Company, par value $0.001 per share.

 

		2.	Company Registration.

 

(a)
        On or prior to each Filing Date, the Company shall prepare and file with the Commission a Registration Statement covering the
resale of all of the Registrable Securities for an offering to be made on a continuous basis pursuant to Rule 415. Each
Registration Statement filed hereunder shall be on Form S-3 (except if the Company is not then eligible to register for
resale the Registrable Securities on Form S-3, in which case such registration shall be on another appropriate form in
accordance herewith, subject to the provisions of Section 2(e)). Subject to the terms of this Agreement, the Company shall
use its best efforts to cause a Registration Statement filed under this Agreement (including, without limitation, under
Section 3(c)) to be declared effective under the Securities Act as promptly as possible after the filing thereof, but in any
event no later than the applicable Effectiveness Date, and shall use its best efforts to keep such Registration Statement
continuously effective under the Securities Act until all Registrable Securities covered by such Registration Statement have
been sold, thereunder or pursuant to Rule 144 (the “Effectiveness Period”). The Company shall
telephonically request effectiveness of a Registration Statement as of 5:00 p.m. Eastern Time on a Trading Day. The Company
shall immediately notify the Holders via facsimile or by e-mail of the effectiveness of a Registration Statement on the same
Trading Day that the Company telephonically confirms effectiveness with the Commission, which shall be the date requested for
effectiveness of such Registration Statement. The Company shall, within the time constraints proscribed by Rule 424 of
the Securities Act, file a final Prospectus with the Commission if so required by Rule 424. Failure to so notify the Holder
within one (1) Trading Day of such notification of effectiveness or failure to file a final Prospectus (if required) as
foresaid shall be deemed an Event under Section 2(d).

 

    	3

    	 

    

  

(b)         Notwithstanding
the registration obligations set forth in Section 2(a), if the Commission informs the Company that all of the Registrable Securities
cannot, as a result of the application of Rule 415, be registered for resale as a secondary offering on a single registration
statement, the Company agrees to promptly inform each of the Holders thereof and use its commercially reasonable efforts to file
amendments to the Initial Registration Statement as required by the Commission, covering the maximum number of Registrable Securities
permitted to be registered by the Commission, on Form S-1 or such other form available to register for resale the Registrable
Securities as a secondary offering, subject to the provisions of Section 2(e); provided, however, that
prior to filing such amendment, the Company shall be obligated to use diligent efforts to advocate with the Commission for the
registration of all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, Compliance
and Disclosure Interpretation 612.09.

 

(c)         Notwithstanding
any other provision of this Agreement and subject to the payment of liquidated damages pursuant to Section 2(d), if the Commission
or any SEC Guidance sets forth a limitation on the number of Registrable Securities permitted to be registered on a particular
Registration Statement as a secondary offering (and notwithstanding that the Company used diligent efforts to advocate with the
Commission for the registration of all or a greater portion of Registrable Securities), unless otherwise directed in writing by
a Holder as to its Registrable Securities, the number of Registrable Securities to be registered on such Registration Statement
will be reduced as follows:

 

		i.	First, the Company shall reduce or eliminate any securities to be included by any Person other
than a Holder;

 

		ii.	Second, the Company shall reduce Registrable Securities represented by Dividend Shares (applied,
in the case that some Dividend Shares may be registered, to the Holders on a pro rata basis based on the total number of Dividend
Shares held by such Holders);

 

		iii.	Third, the Company shall reduce Registrable Securities represented by Preemptive Shares (applied,
in the case that some Preemptive Shares may be registered, to the Holders on a pro rata basis based on the total number of Preemptive
Shares held by such Holders); and

 

		iv.	Fourth, the Company shall reduce Registrable Securities represented by Conversion Shares (applied,
in the case that some Conversion Shares may be registered, to the Holders on a pro rata basis based on the total number of Conversion
Shares held by such Holders).

 

    	4

    	 

    

  

In the event of a cutback hereunder,
the Company shall give the Holder at least five (5) Trading Days prior written notice along with the calculations as to such Holder’s
allotment. In the event the Company amends the Initial Registration Statement in accordance with the foregoing, the Company will
use its best efforts to file with the Commission, as promptly as allowed by Commission or SEC Guidance provided to the Company
or to registrants of securities in general, one or more registration statements on Form S-3 or such other form available to register
for resale those Registrable Securities that were not registered for resale on the Initial Registration Statement, as amended.

 

(d)         If:
(i) the Initial Registration Statement is not filed on or prior to its Filing Date (if the Company files a Registration Statement
without affording the Holders the opportunity to review and comment on the same as required by Section 3(a) herein, the Company
shall be deemed to have not satisfied this clause (i)), or (ii) the Company fails to file with the Commission a request for acceleration
of a Registration Statement in accordance with Rule 461 promulgated by the Commission pursuant to the Securities Act, within five
(5) Trading Days of the date that the Company is notified (orally or in writing, whichever is earlier) by the Commission that such
Registration Statement will not be “reviewed” or will not be subject to further review, or (iii) prior to the effective
date of a Registration Statement, the Company fails to file a pre-effective amendment and otherwise respond in writing to comments
made by the Commission in respect of such Registration Statement within twenty (20) Business Days after the receipt of comments
by or notice from the Commission that such amendment is required in order for such Registration Statement to be declared effective,
or (iv) a Registration Statement registering for resale all of the Registrable Securities is not declared effective by the Commission
by the Effectiveness Date of the Initial Registration Statement, or (v) after the effective date of a Registration Statement, such
Registration Statement ceases for any reason to remain continuously effective as to all Registrable Securities included in such
Registration Statement, or the Holders are otherwise not permitted to utilize the Prospectus therein to resell such Registrable
Securities, for more than fifteen (15) calendar days or more than an aggregate of thirty (30) calendar days (which need not be
consecutive calendar days) during any 12-month period (any such failure or breach being referred to as an “Event”,
and for purposes of clauses (i) and (iv), the date on which such Event occurs, and for purpose of clause (ii) the date on which
such five (5) Trading Day period is exceeded, and for purpose of clause (iii) the date which such twenty (20) day period is exceeded,
and for purpose of clause (v) the date on which such fifteen (15) or thirty (30) calendar day period, as applicable, is exceeded
being referred to as “Event Date”), then, in addition to any other rights the Holders may have hereunder or
under applicable law, on each such Event Date and on each monthly anniversary of each such Event Date (if the applicable Event
shall not have been cured by such date) until the applicable Event is cured, the Company shall pay to each Holder an amount in
cash, as partial liquidated damages and not as a penalty, equal to one-half percent (0.5%) of the aggregate purchase price paid
by such Holder pursuant to the Purchase Agreement for the Registrable Securities held by Holder on each such Event Date. The maximum
aggregate liquidated damages payable to a Holder pursuant to this Section 2(d) shall be 10% of the aggregate Subscription Amount
paid by such Holder pursuant to the Purchase Agreement. If the Company fails to pay any partial liquidated damages pursuant to
this Section in full within seven days after the date payable, the Company will pay interest thereon at a rate of 16% per annum
(or such lesser maximum amount that is permitted to be paid by applicable law) to the Holder, accruing daily from the date such
partial liquidated damages are due until such amounts, plus all such interest thereon, are paid in full. The partial liquidated
damages pursuant to the terms hereof shall apply on a daily pro rata basis for any portion of a month prior to the cure of an Event.

 

    	5

    	 

    

  

(e)         If
Form S-3 is not available for the registration of the resale of Registrable Securities hereunder, the Company shall (i) register
the resale of the Registrable Securities on another appropriate form and (ii) undertake to register the Registrable Securities
on Form S-3 as soon as such form is available, provided that the Company shall maintain the effectiveness of the Registration
Statement then in effect until such time as a Registration Statement on Form S-3 covering the Registrable Securities has been declared
effective by the Commission.

 

(f)           If,
at any time during the Effectiveness Period, there is not an effective Registration Statement covering all of the Registrable Securities
and the Company shall determine to prepare and file with the Commission a registration statement relating to an offering for its
own account or the account of others under the Securities Act of any of its equity securities, other than on Form S-4 or Form S-8
(each as promulgated under the Securities Act) or their then equivalents relating to equity securities to be issued solely in connection
with any acquisition of any entity or business or equity securities issuable in connection with the Company’s stock option
or other employee benefit plans, then the Company shall deliver to each Holder a written notice of such determination and, if within
fifteen days after the date of the delivery of such notice, any such Holder shall so request in writing, the Company shall include
in such registration statement all or any part of such Registrable Securities such Holder requests to be registered, subject to
the provisions set forth below in this Section 3(f), provided however, that notwithstanding any other
provisions of this Section 2(g), if the Commission or any SEC Guidance sets forth a limitation on the number of Registrable Securities
permitted to be registered on such Registration Statement (and notwithstanding that the Company used diligent efforts to advocate
with the Commission for the registration of all or a greater portion of the Registrable Securities), unless otherwise directed
in writing by a Holder as to its Registrable Securities, the number of Registrable Securities to be registered on such Registration
Statement will be reduced according to the cut-back provisions provided for in Section 2(c). The Company shall have the right to
terminate or withdraw any registration initiated by it under this Section 3(f) before the effective date of such registration,
whether or not any Holder has elected to include Registrable Securities in such registration. If any applicable registration statement
under this Section 3(f) involves an underwritten offering of the Company’s equity securities, the Company shall
not be required to include any of the Registrable Securities of a Holder in such underwriting unless such Holder accepts the terms
of the underwriting as agreed upon between the Company and its underwriters, and then only in such quantity as the underwriters
in their sole discretion determine will not jeopardize the success of the offering by the Company. If the total number of securities,
including Registrable Securities, requested by stockholders to be included in such offering exceeds the number of securities to
be sold (other than by the Company) that the underwriters in their reasonable discretion determine is compatible with the success
of the offering, then the Company shall be required to include in the offering only that number of such securities, including Registrable
Securities, which the underwriters and the Company in their sole discretion determine will not jeopardize the success of the offering.
If the underwriters determine that less than all of the Registrable Securities requested to be registered can be included in such
offering, then the Company will promptly so advise each Holder of Registrable Securities that has requested registration, and will
include in such registration: first, Company securities which the Company desires to include in such registration; and second,
Registrable Securities requested to be included therein, allocated pro rata among the holders of Registrable Securities based on
the number of Registrable Securities with respect to which each such holder has requested registration (provided, that in no event
shall the Registrable Securities included in such offering be less than 30% of the Registrable Securities requested to be included
in such offering by the Holders thereof); and third, other securities requested to be included in such registrations, allocated
pro rata among the holders thereof based on the number of such other securities with respect to which such holder has requested
registration; in each case until the aggregate number of securities included in such registration is equal to the number thereof
that, in the opinion of such managing underwriter, can be sold without adversely affecting the marketability thereof.

 

    	6

    	 

    

  

3.          Registration
Procedures. In connection with the Company’s registration obligations hereunder, the Company shall:

 

(a)         Not
less than five (5) Trading Days prior to the filing of each Registration Statement and not less than one (1) Trading Day prior
to the filing of any related Prospectus or any amendment or supplement thereto (including any document that would be incorporated
or deemed to be incorporated therein by reference), the Company shall (i) furnish to each Holder copies of all such documents
proposed to be filed, which documents (other than those incorporated or deemed to be incorporated by reference) will be subject
to the review of such Holders, and (ii) cause its officers and directors, counsel and independent registered public accountants
to respond to such inquiries as shall be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct
a reasonable investigation within the meaning of the Securities Act. Notwithstanding the above, the Company shall not be obligated
to provide the Holders advance copies of any universal shelf registration statement registering securities in addition to those
required hereunder, or any Prospectus prepared thereto. The Company shall not file a Registration Statement or any such Prospectus
or any amendments or supplements thereto to which the Holders of a majority of the Registrable Securities shall reasonably object
in good faith, provided that, the Company is notified of such objection in writing no later than five (5) Trading Days after the
Holders have been so furnished copies of a Registration Statement or one (1) Trading Day after the Holders have been so furnished
copies of any related Prospectus or amendments or supplements thereto. Each Holder agrees to furnish to the Company a completed
questionnaire in the form attached to this Agreement as Annex A (a “Selling Stockholder Questionnaire”)
on a date that is not less than two (2) Trading Days prior to the Filing Date or by the end of the fourth (4th) Trading
Day following the date on which such Holder receives draft materials in accordance with this Section.

 

    	7

    	 

    

  

(b)         (i)
Prepare and file with the Commission such amendments, including post-effective amendments, to a Registration Statement and the
Prospectus used in connection therewith as may be necessary to keep a Registration Statement continuously effective as to the applicable
Registrable Securities for the Effectiveness Period and prepare and file with the Commission such additional Registration Statements
in order to register for resale under the Securities Act all of the Registrable Securities, (ii) cause the related Prospectus to
be amended or supplemented by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented
or amended, to be filed pursuant to Rule 424, (iii) respond as promptly as reasonably possible to any comments received from the
Commission with respect to a Registration Statement or any amendment thereto and provide as promptly as reasonably possible to
the Holders true and complete copies of all correspondence from and to the Commission relating to a Registration Statement (provided
that, the Company shall excise any information contained therein which would constitute material non-public information regarding
the Company or any of its Subsidiaries), and (iv) comply in all material respects with the applicable provisions of the Securities
Act and the Exchange Act with respect to the disposition of all Registrable Securities covered by a Registration Statement during
the applicable period in accordance (subject to the terms of this Agreement) with the intended methods of disposition by the Holders
thereof set forth in such Registration Statement as so amended or in such Prospectus as so supplemented.

 

(c)         If
during the Effectiveness Period, the number of Registrable Securities at any time exceeds 100% of the number of shares of Common
Stock then registered in a Registration Statement (other than for limitations set forth in Section 2(c)), then the Company shall
file as soon as reasonably practicable, but in any case prior to the applicable Filing Date, an additional Registration Statement
covering the resale by the Holders of not less than the number of such Registrable Securities.

 

    	8

    	 

    

  

(d)         Notify
the Holders of Registrable Securities to be sold (which notice shall, pursuant to clauses (iii) through (vi) hereof, be accompanied
by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably possible
(and, in the case of (i)(A) below, not less than one (1) Trading Day prior to such filing) and (if requested by any such Person)
confirm such notice in writing no later than one (1) Trading Day following the day (i)(A) when a Prospectus or any Prospectus supplement
or post-effective amendment to a Registration Statement is proposed to be filed, (B) when the Commission notifies the Company whether
there will be a “review” of such Registration Statement and whenever the Commission comments in writing on such Registration
Statement, and (C) with respect to a Registration Statement or any post-effective amendment, when the same has become effective,
(ii) of any request by the Commission or any other federal or state governmental authority for amendments or supplements to a Registration
Statement or Prospectus or for additional information, (iii) of the issuance by the Commission or any other federal or state governmental
authority of any stop order suspending the effectiveness of a Registration Statement covering any or all of the Registrable Securities
or the initiation of any Proceedings for that purpose, (iv) of the receipt by the Company of any notification with respect to the
suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction,
or the initiation or threatening of any Proceeding for such purpose, (v) of the occurrence of any event or passage of time that
makes the financial statements included in a Registration Statement ineligible for inclusion therein or any statement made in a
Registration Statement or Prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any
material respect or that requires any revisions to a Registration Statement, Prospectus or other documents so that, in the case
of a Registration Statement or the Prospectus, as the case may be, it will not contain any untrue statement of a material fact
or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading, and (vi) of the occurrence or existence of any pending corporate development with respect
to the Company that the Company believes may be material and that, in the determination of the Company, makes it not in the best
interest of the Company to allow continued availability of a Registration Statement or Prospectus, provided, however,
in no event shall any such notice contain any information which would constitute material, non-public information regarding the
Company or any of its Subsidiaries.

 

(e)         Use
its best efforts to avoid the issuance of, or, if issued, obtain the withdrawal of (i) any order stopping or suspending the effectiveness
of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable
Securities for sale in any jurisdiction, at the earliest practicable moment.

 

(f)           Furnish
to each Holder, without charge, at least one conformed copy of each such Registration Statement and each amendment thereto, including
financial statements and schedules, all documents incorporated or deemed to be incorporated therein by reference to the extent
requested by such Person, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated
by reference) promptly after the filing of such documents with the Commission; provided, that any such item which is available
on the EDGAR system (or successor thereto) need not be furnished in physical form.

 

(g)         Subject
to the terms of this Agreement, the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto
by each of the selling Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus
and any amendment or supplement thereto, except after the giving of any notice pursuant to Section 3(d).

 

    	9

    	 

    

  

(h)         The
Company shall cooperate with any broker-dealer through which a Holder proposes to resell its Registrable Securities in effecting
a filing with the FINRA Corporate Financing Department pursuant to FINRA Rule 5110, as requested by any such Holder and the Company
or any such broker-dealer shall pay the filing fee required by such filing within two (2) Business Days of request therefor.

 

(i)          Prior
to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or qualify or cooperate
with the selling Holders in connection with the registration or qualification (or exemption from the Registration or qualification)
of such Registrable Securities for the resale by the Holder under the securities or Blue Sky laws of such jurisdictions within
the United States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom)
effective during the Effectiveness Period and to do any and all other acts or things reasonably necessary to enable the disposition
in such jurisdictions of the Registrable Securities covered by each Registration Statement; provided, that, the Company shall not
be required to qualify generally to do business in any jurisdiction where it is not then so qualified, subject the Company to any
material tax in any such jurisdiction where it is not then so subject or file a general consent to service of process in any such
jurisdiction.

 

(j)          If
requested by a Holder, cooperate with such Holder to facilitate the timely preparation and delivery of certificates representing
Registrable Securities to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free,
to the extent permitted by the Purchase Agreement, of all restrictive legends, and to enable such Registrable Securities to be
in such denominations and registered in such names as any such Holder may request.

 

(k)         Upon
the occurrence of any event contemplated by Section 3(d), as promptly as reasonably possible under the circumstances taking into
account the Company’s good faith assessment of any adverse consequences to the Company and its stockholders of the premature
disclosure of such event, prepare a supplement or amendment, including a post-effective amendment, to a Registration Statement
or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file
any other required document so that, as thereafter delivered, neither a Registration Statement nor such Prospectus will contain
an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein, in light of the circumstances under which they were made, not misleading. If the Company notifies the Holders
in accordance with clauses (iii) through (vi) of Section 3(d) above to suspend the use of any Prospectus until the requisite changes
to such Prospectus have been made, then the Holders shall suspend use of such Prospectus. The Company will use its best efforts
to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company shall be entitled to exercise
its right under this Section 3(k) to suspend the availability of a Registration Statement and Prospectus, subject to the payment
of partial liquidated damages otherwise required pursuant to Section 2(d), for a period not to exceed 60 calendar days (which need
not be consecutive days) in any 12-month period.

 

(l)          Comply
with all applicable rules and regulations of the Commission.

 

    	10

    	 

    

  

(m)        From
and after the date the Company becomes eligible to use Form S-3, the Company shall use its best efforts to maintain eligibility
for use of Form S-3 (or any successor form thereto) for the registration of the resale of Registrable Securities.

 

(n)         The
Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock
beneficially owned by such Holder and, if required by the Commission, the natural persons thereof that have voting and dispositive
control over the shares. During any periods that the Company is unable to meet its obligations hereunder with respect to the registration
of the Registrable Securities solely because any Holder fails to furnish such information within three Trading Days of the Company’s
request, any liquidated damages that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise
occur solely because of such delay shall be suspended as to such Holder only, until such information is delivered to the Company.

 

4.          Additional Obligations
Regarding Registrations.

 

(a)         Each
Holder covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable to
it (unless an exemption therefrom is available) in connection with sales of Registrable Securities pursuant to a Registration Statement.

 

(b)         By
its acquisition of Registrable Securities, each Holder agrees that, upon receipt of a notice from the Company of the occurrence
of any event of the kind described in Section 3(d)(iii) through (vi), such Holder will forthwith discontinue disposition of such
Registrable Securities under a Registration Statement until it is advised in writing (the “Advice”) by the Company
that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will use its
best efforts to ensure that the use of the Prospectus may be resumed as promptly as is practicable. The Company agrees and acknowledges
that any periods during which the Holder is required to discontinue the disposition of the Registrable Securities hereunder shall
be subject to the provisions of Section 2(d).

 

(c)         Neither
the Company nor any of its security holders (other than the Holders in such capacity pursuant hereto) may include securities of
the Company other than the Registrable Securities in any Registration Statements.

 

    	11

    	 

    

  

5.          Registration
Expenses. All fees and expenses incident to the performance of or compliance with, this Agreement by the Company shall be borne
by the Company whether or not any Registrable Securities are sold pursuant to a Registration Statement. The fees and expenses referred
to in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation,
fees and expenses of the Company’s counsel and independent registered public accountants) (A) with respect to filings made
with the Commission, (B) with respect to filings required to be made with any Trading Market on which the Common Stock is then
listed for trading, (C) in compliance with applicable state securities or Blue Sky laws reasonably agreed to by the Company in
writing (including, without limitation, fees and disbursements of counsel for the Company in connection with Blue Sky qualifications
or exemptions of the Registrable Securities) and (D) if not previously paid by the Company in connection with an Issuer Filing,
with respect to any filing that may be required to be made by any broker through which a Holder intends to make sales of Registrable
Securities with FINRA pursuant to FINRA Rule 5110, so long as the broker is receiving no more than a customary brokerage commission
in connection with such sale, (ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable
Securities), (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel for the Company, (v) Securities
Act liability insurance, if the Company so desires such insurance, and (vi) fees and expenses of all other Persons retained by
the Company in connection with the consummation of the transactions contemplated by this Agreement. In addition, the Company shall
be responsible for all of its internal expenses incurred in connection with the consummation of the transactions contemplated by
this Agreement (including, without limitation, all salaries and expenses of its officers and employees performing legal or accounting
duties), the expense of any annual audit and the fees and expenses incurred in connection with the listing of the Registrable Securities
on any securities exchange as required hereunder. In no event shall the Company be responsible for any broker or similar commissions
of any Holder or, except to the extent provided for in the Transaction Documents, any legal fees or other costs of the Holders.

 

6.          Indemnification.

 

(a)         Indemnification
by the Company. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder,
the officers, directors, members, partners, agents, brokers (including brokers who offer and sell Registrable Securities as principal
as a result of a pledge or any failure to perform under a margin call of Common Stock), investment advisors and employees (and
any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or
any other title) of each of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities
Act or Section 20 of the Exchange Act) and the officers, directors, members, stockholders, partners, agents and employees (and
any other Persons with a functionally equivalent role of a Person holding such titles, notwithstanding a lack of such title or
any other title) of each such controlling Person, to the fullest extent permitted by applicable law, from and against any and all
losses, claims, damages, liabilities, costs (including, without limitation, reasonable attorneys’ fees) and expenses (collectively,
“Losses”), as incurred, arising out of or relating to (1) any untrue or alleged untrue statement of a material
fact contained in a Registration Statement, any Prospectus or any form of prospectus or in any amendment or supplement thereto
or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required
to be stated therein or necessary to make the statements therein (in the case of any Prospectus or supplement thereto, in light
of the circumstances under which they were made) not misleading or (2) any violation or alleged violation by the Company of the
Securities Act, the Exchange Act or any state securities law, or any rule or regulation thereunder, in connection with the performance
of its obligations under this Agreement, except to the extent, but only to the extent, that (i) such untrue statements or omissions
are based solely upon information regarding such Holder furnished in writing to the Company by such Holder expressly for use therein,
or to the extent that such information relates to such Holder or such Holder’s proposed method of distribution of Registrable
Securities and was reviewed and expressly approved in writing by such Holder expressly for use in a Registration Statement, such
Prospectus or in any amendment or supplement thereto or (ii) in the case of an occurrence of an event of the type specified in
Section 3(d)(iii)-(vi), the use by such Holder of an outdated, defective or otherwise unavailable Prospectus after the Company
has notified such Holder in writing that the Prospectus is outdated, defective or otherwise unavailable for use by such Holder
and prior to the receipt by such Holder of the Advice contemplated in Section 7(d), but only if and to the extent that following
the receipt of the Advice the misstatement or omission giving rise to such Loss would have been corrected. The Company shall notify
the Holders promptly of the institution, threat or assertion of any Proceeding arising from or in connection with the transactions
contemplated by this Agreement of which the Company is aware. Such indemnity shall remain in full force and effect regardless of
any investigation made by or on behalf of such indemnified person and shall survive the transfer of any Registrable Securities
by any of the Holders in accordance with Section 7(h).

 

    	12

    	 

    

  

(b)         Indemnification
by Holders. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers,
agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section
20 of the Exchange Act), and the directors, officers, agents or employees of such controlling Persons, to the fullest extent permitted
by applicable law, from and against all Losses, as incurred, to the extent arising out of or based solely upon: (x) such Holder’s
failure to comply with any applicable prospectus delivery requirements of the Securities Act through no fault of the Company or
(y) any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any Prospectus, or in any
amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission
of a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus or
supplement thereto, in light of the circumstances under which they were made) not misleading (i) to the extent, but only to the
extent, that such untrue statement or omission is contained in any information so furnished in writing by such Holder to the Company
expressly for inclusion in such Registration Statement or such Prospectus or (ii) to the extent, but only to the extent, that such
information relates to such Holder’s proposed method of distribution of Registrable Securities and was reviewed and expressly
approved in writing by such Holder expressly for use in a Registration Statement, such Prospectus or in any amendment or supplement
thereto or (iii) in the case of an occurrence of an event of the type specified in Section 3(d)(iii)-(vi), to the extent, but only
to the extent, related to the use by such Holder of an outdated, defective or otherwise unavailable Prospectus after the Company
has notified such Holder in writing that the Prospectus is outdated, defective or otherwise unavailable for use by such Holder
and prior to the receipt by such Holder of the Advice contemplated in Section 7(d), but only if and to the extent that following
the receipt of the Advice the misstatement or omission giving rise to such Loss would have been corrected. In no event shall the
liability of any selling Holder under this Section 6(b) be greater in amount than the dollar amount of the net proceeds actually
received by such Holder upon the sale of the Registrable Securities giving rise to such indemnification obligation.

 

    	13

    	 

    

  

(c)         Conduct
of Indemnification Proceedings. If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder
(an “Indemnified Party”), such Indemnified Party shall promptly notify the Person from whom indemnity is sought
(the “Indemnifying Party”) in writing, and the Indemnifying Party shall have the right to assume the defense
thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses
incurred in connection with defense thereof; provided, that, the failure of any Indemnified Party to give such notice shall not
relieve the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that
it shall be finally determined by a court of competent jurisdiction (which determination is not subject to appeal or further review)
that such failure shall have materially and adversely prejudiced the Indemnifying Party.

 

An Indemnified
Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof, but the
fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying Party
has agreed in writing to pay such fees and expenses, (2) the Indemnifying Party shall have failed promptly to assume the defense
of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding, or (3) the named
parties to any such Proceeding (including any impleaded parties) include both such Indemnified Party and the Indemnifying Party,
and counsel to the Indemnified Party shall reasonably believe that a material conflict of interest is likely to exist if the same
counsel were to represent such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies
the Indemnifying Party in writing that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying
Party shall not have the right to assume the defense thereof and the reasonable fees and expenses of no more than one separate
counsel shall be at the expense of the Indemnifying Party). The Indemnifying Party shall not be liable for any settlement of any
such Proceeding effected without its written consent, which consent shall not be unreasonably withheld or delayed. No Indemnifying
Party shall, without the prior written consent of the Indemnified Party, effect any settlement of any pending Proceeding in respect
of which any Indemnified Party is a party, unless such settlement includes an unconditional release of such Indemnified Party from
all liability on claims that are the subject matter of such Proceeding.

 

Subject to
the terms of this Agreement, all reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses
to the extent incurred in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with
this Section) shall be paid to the Indemnified Party, as incurred, within ten Trading Days of written notice thereof to the Indemnifying
Party; provided, that, the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and
expenses applicable to such actions for which such Indemnified Party is finally determined by a court of competent jurisdiction
(which determination is not subject to appeal or further review) not to be entitled to indemnification hereunder.

 

    	14

    	 

    

  

(d)         Contribution.
If the indemnification under Section 6(a) or 6(b) is unavailable to an Indemnified Party or insufficient to hold an Indemnified
Party harmless for any Losses, then each Indemnifying Party shall contribute to the amount paid or payable by such Indemnified
Party, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection
with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations.
The relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether
any action in question, including any untrue or alleged untrue statement of a material fact or omission or alleged omission of
a material fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party,
and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such action, statement
or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations
set forth in this Agreement, any reasonable attorneys’ or other fees or expenses incurred by such party in connection with
any Proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for
in this Section was available to such party in accordance with its terms.

 

The parties
hereto agree that it would not be just and equitable if contribution pursuant to this Section 6(d) were determined by pro rata
allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the
immediately preceding paragraph. Notwithstanding the provisions of this Section 6(d), no Holder shall be required to contribute
pursuant to this Section 6(d), in the aggregate, any amount in excess of the amount by which the net proceeds actually received
by such Holder from the sale of the Registrable Securities subject to the Proceeding exceeds the amount of any damages that such
Holder has otherwise been required to pay by reason of such untrue or alleged untrue statement or omission or alleged omission.

 

The indemnity
and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have to
the Indemnified Parties.

 

7.          Confidentiality; Disclosures.

 

(a)          Confidential
Information. The disclosure and exchange of Confidential Information (as defined in the CNDA) between the Company and Purchaser
(including any Purchaser board observer) shall be governed solely by the terms of the Corporate Non-Disclosure Agreement No. 11663,
dated November 7, 2014, and Intel Capital Equity Corporate Non-Disclosure Agreement No. 70107714, dated December 23, 2014
(collectively, the “CNDA”) executed between the Company and Purchaser; provided, however, that the disclosure
and exchange of confidential information between the Company and Purchaser that is specifically covered by another agreement (other
than a Transaction Document) executed between the Company and Purchaser shall be governed by the terms of such other agreement.
The Company agrees that no confidentiality obligation or restriction contained in any of the Transaction Documents (except for
this Agreement) shall be binding upon Purchaser.

 

    	15

    	 

    

  

(b)         Disclosure.
The terms and conditions of the definitive agreements, including their existence, would be considered confidential information
and would not be disclosed by the Company to any third party except in accordance with the provisions set forth in this Section
7(b). No announcement regarding the terms of the Transaction Documents or Purchaser in a press release, conference, advertisement,
announcement, professional or trade publication, mass marketing materials or otherwise to the general public, other than in filings
required by the Exchange Act may be made without the prior written consent of Purchaser. The Company and Purchaser have agreed,
or will agree prior to the Closing, upon the form of a press release to be issued by the Company following the Closing. Notwithstanding
the foregoing, (a) the Company or Purchaser may disclose any of the terms of the Transaction Documents to its current or bona
fide prospective investors, employees, investment bankers, lenders, accountants and attorneys, in each case only where such persons
or entities are subject to appropriate nondisclosure obligations; (b) Purchaser may disclose its investment in the Company
and the terms of the investment to third parties or to the public at its sole discretion, and, if it does so, the Company would
have the right to disclose to third parties any information disclosed in a press release or other public announcement by Purchaser;
and (c) the Company may disclose, if required by applicable law, rules or regulations, in its Exchange Act filings that Purchaser
is an investor in the Company, provided that the final form of the disclosure is approved in advance in writing by Purchaser. To
the extent required by the rules and regulations of the SEC, upon the advice of counsel, the Company may file the definitive agreements
as exhibits to its Exchange Act reports; provided, however, that the Company agrees to seek confidential treatment
of any portions of those documents as reasonably requested by Purchaser, and provided further, that the Company provide
Purchaser with drafts of confidential treatment requests and redacted copies of the agreements at least three (3) business days
prior to the filing thereof. In the event that the Company is requested or becomes legally compelled (including, without limitation,
pursuant to securities laws and regulations other than as set forth above) to disclose the existence or the terms of the Transaction
Documents in contravention of the provisions of this Section 7, the Company shall provide Purchaser with prompt written notice
of that fact so that the appropriate party may seek (with the cooperation and reasonable efforts of the other parties) a protective
order, confidential treatment or other appropriate remedy. In such event, the Company shall furnish only that portion of the information
which is legally required and shall exercise reasonable efforts to obtain reliable assurance that confidential treatment will be
accorded such information to the extent reasonably requested by Purchaser.

 

    	16

    	 

    

  

8.          Board Matters.

 

(a)         Composition
of Board. At the Closing, the board of directors of the Company (the “Board”) will consist of seven (7)
members, including the two (2) individuals nominated and elected by Purchaser as the holder of a majority of the Series A Preferred
Stock (the “Series A Directors”), unless such individuals have not yet been nominated by the Purchaser prior
to the Closing, in which case there shall be two vacancies at the time of the Closing and the Series A Directors shall take their
seats upon the nomination and election by Purchaser, and the Company shall take all necessary actions to cause such individuals
to be appointed to the Board. Each Series A Director will be appropriately qualified to serve as a director of the Company,
as reasonably determined by Purchaser. At least one of the Series A Directors shall qualify as an “independent director”
as that term is used in the listing rules or requirements applicable to the Company or, if no such rules or requirements are applicable,
then the Nasdaq listing rules and requirements. Subject to the foregoing provisions of this Section 8(a), for so long
as the holders of Series A Preferred Stock have the right as a separate class pursuant to the Certificate of Designation to
nominate and elect one or more directors to the Board, the Company shall take all necessary actions and any and all times to cause
such individuals so nominated and elected as Series A Directors to be appointed to the Board.

 

(b)         Board
Observer. The Company will permit a representative of Purchaser (the “Observer”), in addition to the Series
A Directors, to attend all meetings of the Board, including executive sessions thereof, of the Board and all committees thereof
(whether in person, telephonic or other) in a non-voting, observer capacity and shall provide to Purchaser, concurrently with the
members of the Board, and in the same manner, notice of such meeting and a copy of all materials provided to such members. A majority
of the Board may request that the Observer recuse himself or herself from portions of meetings of the Board or omit to provide
the Observer with certain information if such members of the Board believe in good faith, based on the advice of Company counsel,
that such recusal or omission is necessary in order to (a) preserve the Company’s attorney-client privilege, (b) fulfill
the Company’s obligations with respect to confidential or proprietary information of third parties, provided, however, that
the Observer shall not be so excluded unless all other persons whose receipt of such materials or presence at a meeting would result
in a violation of such third party confidentiality obligations are also excluded, or (c) avoid a conflict of interest in the
event that the Board intends to discuss or vote upon or distribute any materials with respect to a matter in which Purchaser has
a material business or financial interest (other than by reason of its interest as a stockholder) that would pose a conflict of
interest for Purchaser as determined in good faith by the Board based upon the advice of the Company’s legal counsel.

 

(c)         Director
Compensation; Meeting Expenses. The Company will compensate each Series A Director in the same manner and to the same
extent as it compensates its other non-employee directors. If a Series A Director is an employee of Purchaser or any of its
Affiliates, the Company will pay the applicable compensation behalf of such Series A Director to Purchaser. The Company shall
reimburse the reasonable out-of-pocket expenses of the Observer and the Series A Directors incurred in connection with attending
all meetings of the Board and committees thereof.

 

    	17

    	 

    

  

(d)         D&O
Insurance; Indemnification. The Company will maintain directors and officers liability insurance with a carrier and in an amount
customary for the Company’s industry and size of business, as determined by the Board, and will enter into a customary indemnification
agreement in a form reasonably acceptable to Purchaser with the Series A Directors. The Company agrees, and its indemnification
agreements shall provide, that its indemnification obligations to the Series A Directors are primary, and indemnification,
if any, provided to the Series A Directors by Purchaser shall be secondary. Prior to any merger, consolidation, change of
control or other similar transaction in which the Company is not the surviving entity, or the sale or transfer by the Company of
all or substantially all of its assets, the Company will require that any successor (whether by merger, operation of law or otherwise)
to the Company assume the Company’s obligations under this Section 8(d) for a period of at least six years.

 

9.          Disclaimer
of Corporate Opportunities. The Company acknowledges that Purchaser may have, from time to time, information that may be of
interest to the Company (“Information”) including, by way of example only, (a) Purchaser’s technologies,
plans and services, (b) current and future investments and acquisitions Purchaser has made, may make, may consider or may
become aware of with respect to other companies and other technologies, products and services, including, without limitation, technologies,
products and services that may be competitive with the Company’s, and (c) developments with respect to the technologies,
products and services, and plans and strategies relating thereto, of other companies, including, without limitation, companies
that may be competitive with the Company. The Company, as a material part of the consideration for this Agreement, hereby (a) agrees
that Purchaser, the Observer and the non-independent Series A Director shall have no duty to disclose any Information to the
Company or permit the Company to participate in any projects or investments based on any Information, or to otherwise take advantage
of any opportunity that may be of interest to the Company if it were aware of such Information, (b) waives, to the fullest
extent permitted by law, any claim based on the corporate opportunity doctrine or otherwise that could limit Purchaser’s
ability to pursue opportunities based on such Information or that would require Purchaser, the Observer or the non-independent
Series A Director to disclose any such Information to the Company or offer any opportunity relating thereto to the Company,
and (c) renounces, to the fullest extent permitted by law, any interest or expectancy of the Company in, or in being offered
an opportunity to participate in, any such opportunities.

 

10.         Public Filings.
The Company shall deliver to an individual designated by Purchaser (a) copies of the Company's 10-K's, 10-Q's, 8-K's and Annual
Reports to Shareholders promptly after such documents are filed with the Securities and Exchange Commission, (b) thirty days prior
to the end of each fiscal year, a copy of the Company’s strategic plan and operating budget (with variance analysis) forecasting
the Company’s revenues, expenses, and cash position on a month-to-month basis for the upcoming fiscal year and (c) copies
of the Company’s monthly financial statements promptly after they are available.

 

    	18

    	 

    

  

11.         Significant
Transactions. The Company shall notify Purchaser promptly, and in any event within 24 hours, of (i) the receipt of any third
party proposal to acquire more than 10% of the voting stock of the Company and (ii) any decision by the Board to commence a process
intended to lead to a proposal by a third party with respect to the acquisition of more than 10% of the voting stock of the Company
(a “Significant Transaction Process”). Upon notification by the Company
to the Purchaser of the commencement of any Significant Transaction Process, the Company shall be obligated to permit Purchaser
to participate in such process as a potential investor or acquirer of the Company, if Purchaser so elects, on the same terms and
conditions as any third party participant. The Company shall not enter into any agreement with any third party that would restrict
the Company’s ability to comply with any of the provisions of this Section 11, and represents that it is not a party
to any such agreement.

 

12.         Business
Combination Statutes. Prior to the Closing, the Company and the Board have taken such actions as are necessary to exempt Purchaser
and any of its Affiliates from the provisions of Section 203 of the Delaware General Corporation Law or otherwise render inapplicable
any other interested shareholder, business combination or control share acquisition or any other similar statute or provision in
the Certificate of Incorporation or Bylaws, and following the Closing, the Company and the Board shall continue to take any actions
that are necessary to ensure that Purchaser and its Affiliates remain exempt, and refrain from taking any such actions that may
have the opposite impact.

 

13.         Miscellaneous.

 

(a)         Remedies.
In the event of a breach by the Company or by a Holder of any of their respective obligations under this Agreement, each Holder
or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement,
including recovery of damages, shall be entitled to specific performance of its rights under this Agreement. Each of the Company
and each Holder agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach
by it of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance
in respect of such breach, it shall not assert or shall waive the defense that a remedy at law would be adequate.

 

(b)         Amendments
and Waivers. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or supplemented,
and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing and signed
by the Company and the Holders of a majority of the then outstanding Registrable Securities (for purposes of clarification, this
includes any Registrable Securities issuable upon exercise or conversion of any Security). If a Registration Statement does not
register all of the Registrable Securities pursuant to a waiver or amendment done in compliance with the previous sentence, then
the number of Registrable Securities to be registered for each Holder shall be reduced pro rata among all Holders and each Holder
shall have the right to designate which of its Registrable Securities shall be omitted from such Registration Statement. Notwithstanding
the foregoing, a waiver or consent to depart from the provisions hereof with respect to a matter that relates exclusively to the
rights of a Holder or some Holders and that does not directly or indirectly affect the rights of other Holders may be given only
by such Holder or Holders of all of the Registrable Securities to which such waiver or consent relates; provided, however,
that the provisions of this sentence may not be amended, modified, or supplemented except in accordance with the provisions of
the first sentence of this Section 13(b). No consideration shall be offered or paid to any Person to amend or consent to a waiver
or modification of any provision of this Agreement unless the same consideration also is offered to all of the parties to this
Agreement.

 

    	19

    	 

    

  

(c)         Notices.
Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be delivered as
set forth in the Purchase Agreement.

 

(d)         Successors
and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each
of the parties and shall inure to the benefit of each Holder. The Company may not assign (except by merger) its rights or obligations
hereunder without the prior written consent of all of the Holders of the then outstanding Registrable Securities. The Purchaser
may assign this Agreement and its rights and obligations hereunder to an Affiliate. Each Holder may assign its respective rights
and obligations under Sections 2 through 6 of this Agreement in the manner and to the Persons as permitted under Section 5.6
of the Purchase Agreement.

 

(e)         No
Inconsistent Agreements. Neither the Company nor any of its Subsidiaries has entered, as of the date hereof, nor shall the
Company or any of its Subsidiaries, on or after the date of this Agreement, enter into any agreement with respect to its securities,
that would have the effect of impairing the rights granted to the Holders in this Agreement or otherwise conflicts with the provisions
hereof. Except as set forth on Schedule 13(e), neither the Company nor any of its Subsidiaries has previously entered
into any agreement granting any registration rights with respect to any of its securities to any Person that have not been satisfied
in full.

 

(f)           Execution
and Counterparts. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other
party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by
facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and
binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if
such facsimile or “.pdf” signature page were an original thereof.

 

(g)         Governing
Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be determined
in accordance with the provisions of the Purchase Agreement.

 

(h)         Cumulative
Remedies. The remedies provided herein are cumulative and not exclusive of any other remedies provided by law.

 

    	20

    	 

    

  

(i)          Severability.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full
force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that
they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be
hereafter declared invalid, illegal, void or unenforceable.

 

(j)          Headings. The headings
in this Agreement are for convenience only, do not constitute a part of the Agreement and shall not be deemed to limit or affect
any of the provisions hereof.

 

(k)          Independent
Nature of Holders’ Obligations and Rights. The obligations of each Holder hereunder are several and not joint with the
obligations of any other Holder hereunder, and no Holder shall be responsible in any way for the performance of the obligations
of any other Holder hereunder. Nothing contained herein or in any other agreement or document delivered at any closing, and no
action taken by any Holder pursuant hereto or thereto, shall be deemed to constitute the Holders as a partnership, an association,
a joint venture or any other kind of group or entity, or create a presumption that the Holders are in any way acting in concert
or as a group or entity with respect to such obligations or the transactions contemplated by this Agreement or any other matters,
and the Company acknowledges that the Holders are not acting in concert or as a group, and the Company shall not asset any such
claim, with respect to such obligations or transactions. Each Holder shall be entitled to protect and enforce its rights, including
without limitation the rights arising out of this Agreement, and it shall not be necessary for any other Holder to be joined as
an additional party in any proceeding for such purpose. The use of a single agreement with respect to the obligations of the Company
contained was solely in the control of the Company, not the action or decision of any Holder, and was done solely for the convenience
of the Company and not because it was required or requested to do so by any Holder. It is expressly understood and agreed that
each provision contained in this Agreement is between the Company and a Holder, solely, and not between the Company and the Holders
collectively and not between and among Holders.

 

********************

(Signature Page Follows)

 

    	21

    	 

    

 

IN WITNESS WHEREOF, the Company and the
Purchaser have executed this Series A Preferred Stock Investor’s Rights Agreement as of the date first written above. 

 

	
        VUZIX CORPORATION,

        a Delaware corporation

	 
	By:	 
	 	Name: 
	 	Title: 

 

	
        INTEL CORPORATION,

        a Delaware corporation

	 
	By:	 
	 	Name:   
	 	Title:   

 

[SIGNATURE PAGE TO VUZIX CORPORATION
SERIES A PREFERRED STOCK INVESTOR’S RIGHTS AGREEMENT]Exhibit 10.3

 

WAIVER AND CONSENT 

 

This Waiver and Consent (“Consent”)
is made and entered into as of December ___, 2014, by and among Vuzix Corporation, a Delaware corporation (the “Company”),
and the parties identified on the signature page hereto (each a “Purchaser” and collectively, “Purchasers”).
Capitalized terms used but not defined herein will have the meanings assigned to them in the Securities Purchase Agreements (as
defined below).

 

WHEREAS, the Company and Purchasers identified
on Exhibit A entered into Securities Purchase Agreements (“Securities Purchase Agreements”) and other
related Transaction Documents (“Transaction Documents”) dated as of June 3, 2014; and

 

WHEREAS, the Company issued to Purchasers
Convertible Notes (the “Notes”) pursuant to the terms of the Securities Purchase Agreements; and

 

WHEREAS, the Company intends to enter into
a financing transaction which (i) is with a strategic investor that will generate gross proceeds of at least Ten Million Dollars
($10,000,000), (ii) is in consideration for securities of the Company which are sold at a minimum effective price of Five Dollars
($5.00) per share of Common Stock, (iii) by its terms would not otherwise trigger the anti-dilution rights of the Purchasers under
Section 5(b) of the Note, and (iv) will not include any price protection anti-dilution rights provisions (other than rights of
participation, “make-whole” options exercisable by the investor for cash (which may, in certain instances, be at a
per share price of less than $5.00) or upon violation this Consent) (the “Proposed Offering”); and

 

WHEREAS, in connection with the Proposed
Offering, Purchasers would be entitled to certain rights of participation and anti-dilution protections in connection with the
Transaction Documents; and

 

WHEREAS, in connection with the Proposed
Offering, the Company and Purchasers agree to the following waivers and consents.

 

NOW, THEREFORE, for good and valuable consideration,
the receipt of which is hereby acknowledged, the Company and Purchasers hereby agree as follows:

 

1.             Provided the Proposed Offering closes on or before
February 27, 2015, Purchasers permanently and irrevocably: (i) waive the anti-dilution protections and other rights set forth in
Section 5(b) of the Notes, (ii) waive any restrictions contained in Section 4.13 of the Securities Purchase Agreement and consent
to the consummation of the Proposed Offering, (iii) waive all rights to participate in the Proposed Offering as such rights are
set forth in Section 4.18 of the Securities Purchase Agreement and (iv) agrees that all future rights of participation set forth
in Section 4.18 of the Securities Purchase Agreement shall be expressly subject to any rights of participation granted to the investor
in the Proposed Offering.

 

2.             The waivers and consents set forth in this Consent
will be effective only if holders of not less than 85% of the outstanding principal amounts of Notes as of December 31, 2014 execute
and deliver this Consent to the Company (which, for the avoidance of doubt, shall satisfy the requirement by the Company to receive
the consent of a Majority in Interest (as defined in the Securities Purchase Agreement) for the waiver of any provision under the
Transaction Documents as set forth in Section 5.5 of the Securities Purchase Agreement); and holders of not less than 70% of the
Company’s outstanding common stock purchase warrants described on Exhibit B hereto execute and deliver to the Company
on or before January 2, 2015, the form of Warrant Waiver annexed hereto as Exhibit C.

 

    	1

    	 

    

  

3.             The undersigned represents to the Company that it
is the holder of the Note in the amounts set forth on Exhibit A hereto, has not transferred or assigned any rights under
the Note to any third party and has the authority to enter into and deliver this Consent. The undersigned further represents to
the Company that it will not transfer or assign the Note or any rights thereunder to a third party unless such third party agrees
to execute a waiver and consent agreeing to the terms set forth herein.

 

4.             This Consent may be executed in counterparts, each
of which shall be deemed an original, but all of which shall together constitute one and the same instrument. This Consent may
be signed and delivered by facsimile or electronically and such facsimile or electronically signed and delivered Consent shall
be enforceable.

 

5.             This Consent will be subject to amendment and/or waiver
as described in the Transaction documents.

 

6.             The invalidity or unenforceability of any provision
hereof will in no way affect the validity or enforceability of any other provision.

 

7.             This Consent shall be included in the definition of
Transaction Documents.

 

8.             All notices, demands, requests, consents, approvals,
and other communications required or permitted in connection with this Consent shall be made and given in the same manner set forth
in Section 5.4 of the Securities Purchase Agreement.

 

9.             This Consent shall be governed by, interpreted and
construed in accordance with the laws of the State of New York without regard to principles of conflicts of laws and as further
described in Section 5.9 of the Securities Purchase Agreement.

 

10.           The parties acknowledge that this Consent is also
being entered into for the benefit of the investor to the Proposed Offering who is hereby made a third party beneficiary of this
Consent with rights of enforcement. Until the sooner of the abandonment of the Proposed Offering or February 27, 2015, this Consent
may not be amended without the consent of such investor.

 

11.           Except as expressly set forth herein,
this Consent shall not be deemed to be a waiver, amendment or modification of any provisions of the Transaction Documents
or of any right, power or remedy of Purchaser, or constitute a waiver of any provision of the Transaction Documents (except
to the extent herein set forth), or any other document, instrument and/or agreement executed or delivered in connection therewith
and any other agreement to which Purchaser may be a party, in each case whether arising before or after the date hereof or as a
result of performance hereunder or thereunder. Except as set forth herein, Purchaser reserves all rights, remedies, powers, or
privileges available under the Transaction Documents and any other agreement to which Purchaser may be a party, at law or
otherwise. This Consent shall not constitute a novation or satisfaction and accord of the Transaction Documents or any
other document, instrument and/or agreement executed or delivered in connection therewith and any other agreement to which Purchaser
may be a party.

 

12.           The Company and the Purchaser acknowledge
that certain information provided to the Purchaser in connection with obtaining this Consent may constitute material, non-public
information related to the Company (the “Proposed Offering MNPI”). The Company agrees that it shall, on or before January
16, 2015, file a Current Report on Form 8-K with the Securities and Exchange Commission disclosing such Proposed Offering MNPI.

 

(Signatures to follow)

 

    	2

    	 

    

 

IN WITNESS WHEREOF, the Company and the
undersigned Purchasers have caused this Waiver to be executed as of the date first written above.

 

	 	VUZIX CORPORATION
	 	the “Company”
	 	 
	 	By:	 

 

“PURCHASER”

 

Name of Purchaser: ____________________________________________________________________

 

Signature of Authorized Signatory of Purchaser:
_____________________________________________

 

Name of Authorized Signatory: ___________________________________________________________

 

Title of Authorized Signatory: ____________________________________________________________ 

 

    	3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}]]